Day-case transfer for percutaneous coronary intervention with adjunctive abciximab in acute coronary syndromes.
Blackman
D J
DJ
Clarke
N R
NR
Orr
W P
WP
Wilkinson
E
E
Beswick
A
A
Coppock
D
D
Sprigings
D C
DC
Banning
A P
AP
D000077284:Abciximab; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy*; D003631:Day Care, Medical; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010360:Patient Transfer; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012017:Referral and Consultation
D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab